Premium
'Plate‐like‐coral' polymer particles with dendritic structure and porous channels: Effective delivery of anti‐cancer drugs
Author(s) -
Amgoth Chander,
Dharmapuri Gangappa,
Patra Sukanya,
Wasnik Kirti,
Gupta Premshankar,
Kalle Arunasree M.,
Paik Pradip
Publication year - 2021
Publication title -
journal of applied polymer science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.575
H-Index - 166
eISSN - 1097-4628
pISSN - 0021-8995
DOI - 10.1002/app.50386
Subject(s) - materials science , polymer , drug delivery , doxorubicin hydrochloride , copolymer , doxorubicin , chemistry , nanotechnology , medicine , surgery , chemotherapy , composite material
' Plate‐like‐coral' shaped polymer capsule (PC‐PLCDB) with dendritic network structure and porous channels has been synthesized and used for therapeutic purposes. First di‐block copolymer [(PEG)‐b‐(L‐AspA) n ] has been synthesized from PEG (polyethylene glycol) and aspartic acid (AspA). Then the biocompatible PC‐PLCDB has been achieved by homogeneous mixing of [(PEG)‐b‐(L‐AspA) n ] and poly‐N‐isopropyl acrylamide (PNIPAM) followed by reprecipitation. Only H‐bonding is responsible for the foundation of self‐assembly of the polymer chains and to form PC‐PLCDB. A huge extent of loading anticancer drug, for example, doxorubicin (DOX) in PC‐PLCDB is possible. in vitro study has been performed to check the therapeutic efficacy of PC‐PLCAD‐DOX formulation on chronic myeloid leukemia cells (K562). The IC 50 has been calculated to be 0.405 (±0.014) ng μg −1 of the formulation. PC‐PLCAD‐DOX inhibits 80% of the cancer cell only by 1.0 μg mL −1 of the formulation. This study reveals that the PC‐PLCAD could be a promising candidate for therapeutic applications.